Edition:
United States

Health News

Photo

AstraZeneca's immunotherapy drug wins key lung cancer approval 3:14am EST

LONDON AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.

More Headlines

Photo

Fear of federal law may prevent gun retailers from storing firearms

(Reuters Health) - What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?

Feb 16 2018

Hospitalized older adults less often tested for flu

(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.

Feb 16 2018

In-person license renewal may reduce crashes involving people with dementia

Reuters Health - Older adults with dementia may be less likely to get in car crashes when they’re required to renew their driver’s licenses in person, a U.S. study suggests.

Feb 16 2018
Photo

Pot Pharm: Booming Canada weed sector plots next-wave medicines

TORONTO Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants. | Video

Feb 16 2018

Health Watch Graphics